documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
17 rows where agency_id = "FDA" and docket_id = "FDA-2012-D-0880" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
agency_id 1
- FDA · 17 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-D-0880-0036 | FDA | None FDA-2012-D-0880 | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017; Draft Guidance for Industry; Final Guidance | Other | Guidance | 2023-06-08T04:00:00Z | 2023 | 6 | 2023-06-08T04:00:00Z | 2024-11-11T21:23:32Z | 1 | 0 | 0900006485ae0c44 | ||
| FDA-2012-D-0880-0035 | FDA | None FDA-2012-D-0880 | Final Guidance for Industry - Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 | Other | Guidance | 2022-05-18T04:00:00Z | 2022 | 5 | 2022-05-18T04:00:00Z | 2024-11-07T00:38:54Z | 1 | 0 | 09000064850894ca | ||
| FDA-2012-D-0880-0034 | FDA | None FDA-2012-D-0880 | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017; Guidance for Industry; Availability | Notice | Notice of Availability | 2022-05-18T04:00:00Z | 2022 | 5 | 2022-05-18T04:00:00Z | 2022-05-18T19:49:37Z | 2022-10702 | 0 | 0 | 090000648508897a | |
| FDA-2012-D-0880-0030 | FDA | None FDA-2012-D-0880 | Draft Guidance for Industry - Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 | Other | Guidance | 2019-11-01T04:00:00Z | 2019 | 11 | 2019-11-01T04:00:00Z | 2024-11-12T23:11:37Z | 1 | 0 | 09000064841152bd | ||
| FDA-2012-D-0880-0029 | FDA | None FDA-2012-D-0880 | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2019-11-01T04:00:00Z | 2019 | 11 | 2019-11-01T04:00:00Z | 2020-01-01T04:59:59Z | 2019-12-21T02:01:25Z | 2019-23875 | 0 | 0 | 0900006484113ec1 |
| FDA-2012-D-0880-0024 | FDA | None FDA-2012-D-0880 | Draft Guidance for Industry on Assessing User Fees Under the Generic Drug User Fee Amendments of 2017 | Other | Guidance | 2017-10-30T04:00:00Z | 2017 | 10 | 2017-10-30T04:00:00Z | 2022-05-19T15:23:06Z | 0 | 0 | 0900006482c22925 | ||
| FDA-2012-D-0880-0023 | FDA | None FDA-2012-D-0880 | Assessing User Fees Under the Generic Drug User Fee Amendments of 2017; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2017-10-30T04:00:00Z | 2017 | 10 | 2017-10-30T04:00:00Z | 2017-12-30T04:59:59Z | 2017-12-29T02:00:42Z | 2017-23526 | 0 | 0 | 0900006482c21d18 |
| FDA-2012-D-0880-0021 | FDA | None FDA-2012-D-0880 | Generic Drug User Fee Amendments of 2012: Questions and Answers Related to Self-Identification of Facilities, Review of Generic Drug Submissions, and Inspections and Compliance; Guidance for Industry; Availability | Notice | Notice of Availability | 2017-07-26T04:00:00Z | 2017 | 7 | 2017-07-26T04:00:00Z | 2017-07-26T13:59:13Z | 2017-15654 | 0 | 0 | 090000648296a012 | |
| FDA-2012-D-0880-0022 | FDA | None FDA-2012-D-0880 | Generic Drug User Fee Amendments of 2012: Questions and Answers Related to User Fee Assessments Guidance for Industry | Other | Guidance | 2017-07-26T04:00:00Z | 2017 | 7 | 2017-07-26T04:00:00Z | 2024-11-07T01:03:50Z | 1 | 0 | 090000648296d644 | ||
| FDA-2012-D-0880-0020 | FDA | None FDA-2012-D-0880 | Final Guidance for Industry Generic Drug User Fee Amendments of 2012 - Questions and Answers Related t User Fee Assessments | Other | Guidance | 2016-12-14T05:00:00Z | 2016 | 12 | 2016-12-14T05:00:00Z | 2024-11-07T23:53:21Z | 1 | 0 | 0900006482409ef4 | ||
| FDA-2012-D-0880-0018 | FDA | None FDA-2012-D-0880 | Generic Drug User Fee Amendments of 2012: Questions and Answers Related to User Fee Assessments; Guidance for Industry; Availability | Notice | Notice of Availability | 2016-11-18T05:00:00Z | 2016 | 11 | 2016-11-18T05:00:00Z | 2016-11-18T17:35:39Z | 2016-27761 | 0 | 0 | 09000064823a05f3 | |
| FDA-2012-D-0880-0019 | FDA | None FDA-2012-D-0880 | Draft Guidance for Generic Drug User Fee Amendments of 2012 Questions and Answers | Other | Guidance | 2016-11-18T05:00:00Z | 2016 | 11 | 2016-11-18T05:00:00Z | 2024-11-12T06:16:24Z | 1 | 0 | 09000064823a0ef6 | ||
| FDA-2012-D-0880-0009 | FDA | None FDA-2012-D-0880 | Draft Guidance for Industry on Generic Drug User Fee Amendments of 2012: Questions and Answers (Revision 1); Reopening of the Comment Period | Notice | General Notice | 2013-11-27T05:00:00Z | 2013 | 11 | 2013-11-27T05:00:00Z | 2013-12-12T04:59:59Z | 2016-11-18T14:46:02Z | 2013-28392 | 0 | 0 | 090000648149c2b6 |
| FDA-2012-D-0880-0006 | FDA | None FDA-2012-D-0880 | Draft Guidance for Industry on Generic Drug User Fee Amendments of 2012: Questions and Answers (Revision 1); Availability | Notice | Notice of Availability | 2013-09-10T04:00:00Z | 2013 | 9 | 2013-09-10T04:00:00Z | 2013-11-27T04:59:59Z | 2016-11-18T14:44:33Z | 2013-21891 | 0 | 0 | 09000064813ebe4c |
| FDA-2012-D-0880-0007 | FDA | None FDA-2012-D-0880 | Draft Guidance for Industry on Generic Drug User Fee Amendments of 2012: Questions and Answers (Revision 1) | Other | Guidance | 2013-09-10T04:00:00Z | 2013 | 9 | 2013-09-10T04:00:00Z | 2024-11-07T22:57:45Z | 1 | 0 | 09000064813eca54 | ||
| FDA-2012-D-0880-0001 | FDA | None FDA-2012-D-0880 | Draft Guidances for Industry: Generic Drug User Fee Amendments of 2012, Questions and Answers | Notice | Notice of Availability | 2012-08-27T04:00:00Z | 2012 | 8 | 2012-08-27T04:00:00Z | 2012-10-27T03:59:59Z | 2012-10-02T02:01:15Z | 2012-20944 | 0 | 0 | 09000064810f2477 |
| FDA-2012-D-0880-0002 | FDA | None FDA-2012-D-0880 | Draft Guidances for Industry: Generic Drug User Fee Amendments of 2012, Questions and Answers | Other | Guidance | 2012-08-27T04:00:00Z | 2012 | 8 | 2012-08-27T04:00:00Z | 2024-11-12T04:51:37Z | 1 | 0 | 09000064810f272a |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;